ClinVar Miner

Submissions for variant NM_006420.3(ARFGEF2):c.4059dup (p.Val1354fs)

dbSNP: rs1600546214
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001009223 SCV001169042 likely pathogenic not provided 2019-01-25 criteria provided, single submitter clinical testing A variant that is likely pathogenic has been identified in the ARFGEF2 gene. The c.4059dupA variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.4059dupA variant in the ARFGEF2 gene causes a frameshift starting with codon Valine 1354, changes this amino acid to a Serine residue and creates a premature Stop codon at position 4 of the new reading frame, denoted p.Val1354SerfsX4. This frameshift variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.4059dupA variant is not observed in large population cohorts (Lek et al., 2016). Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.